Hamilton Claire, Anand Paras K
Infectious Diseases and Immunity, Department of Medicine, Imperial College London, The Commonwealth Building, Du Cane Road, London, W12 0NN, UK.
F1000Res. 2019 May 17;8. doi: 10.12688/f1000research.18557.1. eCollection 2019.
The NLRP3 inflammasome is a multimeric protein complex that cleaves caspase-1 and the pro-inflammatory cytokines interleukin 1 beta (IL-1β) and IL-18. Dysregulated NLRP3 inflammasome signalling is linked to several chronic inflammatory and autoimmune conditions; thus, understanding the activation mechanisms of the NLRP3 inflammasome is essential. Studies over the past few years have implicated vital roles for distinct intracellular organelles in both the localisation and assembly of the NLRP3 inflammasome. However, conflicting reports exist. Prior to its activation, NLRP3 has been shown to be resident in the endoplasmic reticulum (ER) and cytosol, although, upon activation, the NLRP3 inflammasome has been shown to assemble in the cytosol, mitochondria, and mitochondria-associated ER membranes by different reports. Finally, very recent work has suggested that NLRP3 may be localised on or adjacent to the Golgi apparatus and that release of mediators from this organelle may contribute to inflammasome assembly. Therefore, NLRP3 may be strategically placed on or in close proximity to these subcellular compartments to both sense danger signals originating from these organelles and use the compartment as a scaffold to assemble the complex. Understanding where and when NLRP3 inflammasome assembly occurs may help identify potential targets for treatment of NLRP3-related disorders.
NLRP3炎性小体是一种多聚体蛋白复合物,可切割半胱天冬酶-1以及促炎细胞因子白细胞介素1β(IL-1β)和IL-18。NLRP3炎性小体信号失调与多种慢性炎症和自身免疫性疾病有关;因此,了解NLRP3炎性小体的激活机制至关重要。过去几年的研究表明,不同的细胞内细胞器在NLRP3炎性小体的定位和组装中发挥着重要作用。然而,存在相互矛盾的报道。在激活之前,NLRP3已被证明存在于内质网(ER)和细胞质中,尽管在激活后,不同的报道显示NLRP3炎性小体在细胞质、线粒体和线粒体相关内质网膜中组装。最后,最近的研究表明,NLRP3可能定位于高尔基体上或其附近,并且从该细胞器释放的介质可能有助于炎性小体的组装。因此,NLRP3可能被战略性地放置在这些亚细胞区室上或其附近,以便感知源自这些细胞器的危险信号,并将该区室用作组装复合物的支架。了解NLRP3炎性小体组装的位置和时间可能有助于确定治疗NLRP3相关疾病的潜在靶点。